Screening, Treatment Cuts Breast Cancer Deaths in Half

TUESDAY, Jan. 9, 2018 -- Breakthroughs in breast cancer screening and treatment have slashed the percentage of women dying from the disease, a new analysis reveals. " Advances in screening and treatment are saving lives, " said lead researcher Sylvia...
Source: - Daily MedNews - Category: General Medicine Source Type: news

Related Links:

Publication date: Available online 21 March 2019Source: European Polymer JournalAuthor(s): Aliyeh Ghamkhari, Farideh Mahmoodzadeh, Marjan Ghorbani, Hamed HamishehkarAbstractGold nanoparticles have been used for centuries in medicine for clinical procedures. In this context, gold nanorods are considered as very promising in cancer therapy. For this purpose, gold nanorods (GNRs) coated by stimuli-responsive thiol-end capped ABC triblock copolymer [poly (metacrylic acid)-block-poly (N-isopropylacrylamide)-block-poly (N,N-dimethylaminoethyl methacrylate)-SH; P(MAAc-b-NiPAAM-b-DMAEMA)-SH] for intracellular delivery of doxorubic...
Source: European Polymer Journal - Category: Chemistry Source Type: research
ConclusionIOUS decreases excision of healthy breast tissue while increasing negative margin rates compared to WL. IOUS can be easily implemented; 11 cases are enough to acquire skills for performing the technique. Savings can be up to 900€ per surgery.
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
Breast cancer care and access to specialists are bright spots.
Source: AJN - Category: Nursing Tags: In the News Source Type: research
Breast imaging computer-aided detection software developer CureMetrix has garnered...Read more on AuntMinnie.comRelated Reading: Mammo AI software yields workflow, economic benefits AI-based CAD software improves breast cancer detection CureMetrix to provide DocPanel with AI mammo software CureMetrix delivers CAD software to Mexican clinic CureMetrix adds to medical advisory board
Source: Headlines - Category: Radiology Source Type: news
Publication date: Available online 21 March 2019Source: Microbial PathogenesisAuthor(s): Marla Karine Amarante, Nathalia de Sousa Pereira, Glauco Akelinghton Freire Vitiello, Maria Angelica Ehara WatanabeAbstractBreast cancer (BC) is a complex and heterogeneous disease whose evolution depends on the tumor-host interaction. This type of cancer occurs when the mammary cells begin to grow wildly and become able to invade nearby tissues and/or promote metastases. Mouse mammary tumor virus (MMTV) is the accepted etiological agent of mammary tumors in mice. The identification of MMTV-like sequences and antigens in human mammary ...
Source: Microbial Pathogenesis - Category: Infectious Diseases Source Type: research
Condition:   Breast Cancer Interventions:   Drug: oral vinorelbine;   Drug: Capecitabine;   Drug: Gemcitabine 1250 mg/m²;   Drug: Gemcitabine 1000 mg/m²;   Drug: Paclitaxel;   Drug: Docetaxel Sponsor:   Pierre Fabre Medicament Completed
Source: - Category: Research Source Type: clinical trials
Conditions:   Early-stage Breast Cancer;   Carbohydrate Engorgement;   Proliferation;   Insulin Resistance;   Estrogen Receptor-positive Breast Cancer Intervention:   Dietary Supplement: PreOP Sponsor:   Helse Stavanger HF Completed
Source: - Category: Research Source Type: clinical trials
Abstract Breast cancer care and access to specialists are bright spots. PMID: 30896471 [PubMed - in process]
Source: The American Journal of Nursing - Category: Nursing Authors: Tags: Am J Nurs Source Type: research
Conclusions: FNA allows sensitive, specific, and safe evaluation and diagnosis of palpable male breast lesions.Acta Cytologica
Source: Acta Cytologica - Category: Cytology Source Type: research
Clinical trials are research studies that test a new drug or therapy in patients who have a disease. These studies are classified as phase I, II, or III depending on their purpose. Phase I: These initial, small studies test promising new drugs that effectively kill cancer cells in laboratory experiments. The goal is to understand the safe dose and capture early evidence of benefit. Phase I trials may be open to patients with any type of cancer, or only certain types of cancers more likely to respond to specific drugs. Generally, fewer than 50 patients are enrolled. Phase II: Once a phase I trial identifies a saf...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Breast Cancer Health Treatments Source Type: blogs
More News: Breast Cancer | Cancer | Cancer & Oncology | General Medicine | Women